During the past decade, Ambulantes Tumorzentrum Spandau; Dres. Benno Mohr und Uwe Peters conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ambulantes Tumorzentrum Spandau; Dres. Benno Mohr und Uwe Peters" are "Breast Cancer" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials), "Triple Negative Breast Cancer" (1 trials), "Triple-Negative Breast Cancer" (1 trials) and "Triple-negative Breast Cancer" (1 trials). Many other conditions were trialed in "Ambulantes Tumorzentrum Spandau; Dres. Benno Mohr und Uwe Peters" in a lesser frequency.

Most popular intervention types in "Ambulantes Tumorzentrum Spandau; Dres. Benno Mohr und Uwe Peters" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (3 trials), "Placebo" (3 trials), "Palbociclib" (2 trials), "Atezolizumab Placebo" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ambulantes Tumorzentrum Spandau; Dres. Benno Mohr und Uwe Peters" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Ambulantes Tumorzentrum Spandau; Dres. Benno Mohr und Uwe Peters". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ambulantes Tumorzentrum Spandau; Dres. Benno Mohr und Uwe Peters, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ambulantes Tumorzentrum Spandau; Dres. Benno Mohr und Uwe Peters, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".